BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 30, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 25, 2008
View Archived Issues
MiddleBrook Soars on FDA OK of Once-Daily Strep Antibiotic
MiddleBrook Pharmaceuticals Inc.'s stock skyrocketed Thursday after the FDA approved its once-daily, extended-release amoxicillin tablet, Moxatag. (BioWorld Today)
Read More
Gilead Tops Estimates; Earnings Driven by Strong HIV Franchise
Read More
Researchers Make Complete Real, Artificial Chromosome
Read More
Orexigen Prices $77M Follow-On as Obesity Trials Move Ahead
Read More
Other News To Note
Read More
Clinic Roundup
Read More